Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2.
The broad antipseudomonal spectrum of the carbapenem BMS-181139 includes clinical strains and laboratory mutants of Pseudomonas aeruginosa that are resistant to imipenem. Unlike other known carbapenems (meropenem, panipenem, biapenem, and BO-2727), which have reduced activity against imipenem-resist...
Salvato in:
| Pubblicato in: | Antimicrob Agents Chemother |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Society for Microbiology (ASM)
1995
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162548/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7726503/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.2.386 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
